Atrion Corp
NASDAQ:ATRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cnova NV
OTC:CNVAF
|
NL |
|
D
|
DS Dansuk Co Ltd
KRX:017860
|
KR |
|
Isuzu Motors Ltd
TSE:7202
|
JP |
|
G
|
Goldstorm Metals Corp
XTSX:GSTM
|
CA |
|
Cosmo Advanced Materials & Technology Co Ltd
KRX:005070
|
KR |
|
Hyundai Home Shopping Network Corp
KRX:057050
|
KR |
|
A
|
Anhui Jiangnan Chemical Industry Co Ltd
SZSE:002226
|
CN |
|
S
|
Shilchar Technologies Ltd
BSE:531201
|
IN |
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IST:SELEC.E
|
TR |
|
A
|
Alligo AB
STO:ALLIGO B
|
SE |
|
Severn Trent PLC
LSE:SVT
|
UK |
|
C
|
Colgate-Palmolive (India) Ltd
BSE:500830
|
IN |
|
S
|
Summa Linguae Technologies SA
WSE:SUL
|
PL |
|
L
|
Landsea Green Properties Co Ltd
HKEX:106
|
HK |
|
E
|
Econergy Renewable Energy Ltd
TASE:ECNR
|
IL |
Atrion Corp
EPS (Diluted)
Atrion Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Atrion Corp
NASDAQ:ATRI
|
EPS (Diluted)
$7
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-6%
|
|
|
Haemonetics Corp
NYSE:HAE
|
EPS (Diluted)
$3
|
CAGR 3-Years
26%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-36%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
EPS (Diluted)
$5
|
CAGR 3-Years
7%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
12%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
EPS (Diluted)
$3
|
CAGR 3-Years
104%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
EPS (Diluted)
$2
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
See Also
What is Atrion Corp's EPS (Diluted)?
EPS (Diluted)
7.1
USD
Based on the financial report for Jun 30, 2024, Atrion Corp's EPS (Diluted) amounts to 7.1 USD.
What is Atrion Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-6%
Over the last year, the EPS (Diluted) growth was -54%. The average annual EPS (Diluted) growth rates for Atrion Corp have been -25% over the past three years , -18% over the past five years , and -6% over the past ten years .
